Relativity Logo
    Relativity
    Relativity Logo
    Relativity
    IdeasPortfolios
    Companies/COYA

    Coya Therapeutics, Inc.(COYA)

    Biotechnology
    Neuroscience Biotech
    BusinessManagementInsider TradingIndustryFinancialsTranscripts
    Company Summary Stats
    H.BearBearishNeutralBullishH.Bull
    50.0
    Insider Trading Score
    Peer Group Scores
    AMLX
    67
    MRNA
    60
    COYA
    50
    KYTX
    50
    BIIB
    50
    DNLI
    50
    TGTX
    50
    CUE
    50
    ALEC
    30
    IONS
    22
    CYTK
    10
    Recent Insider Trades
    Filing DateInsiderType10b5-1Net SharesOwnership changeAvg. PriceValueFiling
    2024-11-14
    SNYDER DAVID S
    Chief Financial Officer
    Purchase
    +1,800
    +25.71%8,800
    $7.19$12,934View SEC filing
    2024-11-13
    Swaminathan Arun
    Chief Executive Officer
    Purchase
    +5,000
    +100.00%10,000
    $7.36$36,797View SEC filing
    2024-11-12
    Grossman Fred
    Chief Medical Officer
    Purchase
    +2,710
    +100.00%2,710
    $7.37$19,973View SEC filing
    2024-11-12
    Swaminathan Arun
    Chief Executive Officer
    Purchase
    +5,000
    +100.00%5,000
    $7.34$36,689View SEC filing
    2024-03-05
    Lee Ann
    Director
    Purchase
    +1,000
    +6.07%17,479
    $3.62$3,620View SEC filing
    2023-01-04
    Berman Howard
    Chief Executive Officer
    Purchase
    +15,000
    +100.00%15,000
    N/AN/AView SEC filing
    2023-01-04
    Lee Ann
    Director
    Purchase
    +15,000
    +334.90%19,479
    N/AN/AView SEC filing
    2023-01-04
    Hepner Adrian
    Chief Medical Officer
    Purchase
    +15,000
    +100.00%15,000
    N/AN/AView SEC filing
    2023-01-04
    SNYDER DAVID S
    Chief Financial Officer
    Purchase
    +10,500
    +100.00%10,500
    N/AN/AView SEC filing
    2023-01-04
    Garren Hideki
    Director
    Purchase
    +3,000
    +100.00%3,000
    N/AN/AView SEC filing
    2023-01-04
    Villalobos Anabella
    Director
    Purchase
    +15,000
    +100.00%15,000
    N/AN/AView SEC filing
    2023-01-04
    GOLDSTEIN DOV A MD
    Director
    Purchase
    +15,000
    +100.00%15,000
    N/AN/AView SEC filing

    1-12 of 12

    Page 1 of 1